Diagnostics & Research · Healthcare
Bill Bonello
Analyst
Craig-Hallum
Equibles does not estimate personal net worth.
About Bill Bonello
Bill Bonello is recorded as Analyst at Craig-Hallum. Bill Bonello has spoken on 15 earnings calls across 7 companies, most recently for GeneDx Holdings Corp. on November 9, 2026. Those appearances were for Guardant Health, Inc. (GH), GeneDx Holdings Corp. (WGS), Sera Prognostics, Inc. (SERA), CareDx, Inc. (CDNA), Neogenomics Inc (NEO) and 2 other companies. The companies whose calls Bill Bonello spoke on are classified in the Healthcare sector.
Bill Bonello on recent calls
“I'm maybe just trying to come at some of these things a little bit different, I guess.”
“Fun to be on a quarter where things are moving in the right direction. Specifically to that, I was hoping to ask sort of a multi-part question on hereditary cancer pricing, just trying to understand a little bit more of the dynamic there.”
“One, about Florida, and then if I could follow up with that about the managed care discussion. But on Florida, first of all, you mentioned, I think, if I heard right, that in Illinois, there's no prior off Is that also true in Florida, and are there any other restrictions in terms of who can be tested in Florida?”
“Just a question on any updated thoughts in terms of guidelines.”
“I just want to see if I have my math right here, and I hope you can follow me. But if I sort of add and subtract all the moving parts, it looks to me like the non-acquisition raise for the second half of the year is about $17 million to $18 million.”
Affiliation history
-
Craig-Hallum
Analyst
Transcript header (unverified)
Current
Company network
Diagnostics & Research · Healthcare
CDNA
Diagnostics & Research · Healthcare
NEO
Diagnostics & Research · Healthcare
MYGN
Diagnostics & Research · Healthcare
SOPH
Health Information Services · Healthcare